Capitano zenzero toothpaste — Competitive Intelligence Brief

Capitano zenzero toothpaste (Capitano zenzero toothpaste) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antibacterial. Area: Dentistry.

phase 3 Antibacterial Dentistry Small molecule

Target snapshot

Capitano zenzero toothpaste (Capitano zenzero toothpaste) — University of Baghdad. Capitano zenzero toothpaste is a topical antibacterial agent that helps prevent tooth decay and gum disease.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Capitano zenzero toothpaste TARGET	Capitano zenzero toothpaste	University of Baghdad	phase 3	Antibacterial
Fetroja	CEFIDEROCOL	Shionogi	marketed	Cephalosporin Antibacterial		2019-01-01
Xenleta	LEFAMULIN	Hong Kong	marketed	Pleuromutilin Antibacterial		2019-01-01
Nuzyra	OMADACYCLINE	Paratek Pharms	marketed	Tetracycline-class Antibacterial [EPC]		2018-01-01
Nuzyra	OMADACYCLINE TOSYLATE	Paratek Pharms	marketed	Tetracycline-class Antibacterial [EPC]		2018-01-01
Baxdela	DELAFLOXACIN	Melinta	marketed	Fluoroquinolone Antibacterial		2017-01-01
Orbactiv	ORITAVANCIN	Melinta Therap	marketed	Lipoglycopeptide Antibacterial		2014-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antibacterial class)

1. University of Baghdad · 1 drug in this class
2. University of Guarulhos · 1 drug in this class
3. University of the Philippines · 1 drug in this class